Skip to main content

Research Repository

Advanced Search

The Synthetic Biology Open Language (SBOL) provides a community standard for communicating designs in synthetic biology

Galdzicki, Michal; Clancy, Kevin P; Oberortner, Ernst; Pocock, Matthew; Quinn, Jacqueline Y; Rodriguez, Cesar A; Roehner, Nicholas; Wilson, Mandy L; Adam, Laura; Anderson, J Christopher; Bartley, Bryan A; Beal, Jacob; Chandran, Deepak; Chen, Joanna; Densmore, Douglas; Endy, Drew; Grünberg, Raik; Hallinan, Jennifer; Hillson, Nathan J; Johnson, Jeffrey D; Kuchinsky, Allan; Lux, Matthew; Misirli, Goksel; Peccoud, Jean; Plahar, Hector A; Sirin, Evren; Stan, Guy-Bart; Villalobos, Alan; Wipat, Anil; Gennari, John H; Myers, Chris J; Sauro, Herbert M

Authors

Michal Galdzicki

Kevin P Clancy

Ernst Oberortner

Matthew Pocock

Jacqueline Y Quinn

Cesar A Rodriguez

Nicholas Roehner

Mandy L Wilson

Laura Adam

J Christopher Anderson

Bryan A Bartley

Jacob Beal

Deepak Chandran

Joanna Chen

Douglas Densmore

Drew Endy

Raik Grünberg

Jennifer Hallinan

Nathan J Hillson

Jeffrey D Johnson

Allan Kuchinsky

Matthew Lux

Jean Peccoud

Hector A Plahar

Evren Sirin

Guy-Bart Stan

Alan Villalobos

Anil Wipat

John H Gennari

Chris J Myers

Herbert M Sauro



Citation

Galdzicki, M., Clancy, K. P., Oberortner, E., Pocock, M., Quinn, J. Y., Rodriguez, C. A., …Sauro, H. M. (2014). The Synthetic Biology Open Language (SBOL) provides a community standard for communicating designs in synthetic biology. Nature Biotechnology, 32(6), 545-550. https://doi.org/10.1038/nbt.2891

Journal Article Type Article
Online Publication Date Jun 6, 2014
Publication Date 2014-06
Deposit Date Jun 15, 2023
Journal Nature Biotechnology
Print ISSN 1087-0156
Electronic ISSN 1546-1696
Publisher Nature Publishing Group
Peer Reviewed Peer Reviewed
Volume 32
Issue 6
Pages 545-550
DOI https://doi.org/10.1038/nbt.2891
Keywords Biomedical Engineering; Molecular Medicine; Applied Microbiology and Biotechnology; Bioengineering; Biotechnology
Additional Information Received: 9 November 2013; Accepted: 20 December 2013; First Online: 6 June 2014; : N.J.H. declares competing financial interests in equity in TeselaGen Biotechnologies, Inc., whose value may indirectly benefit (or may be perceived to indirectly benefit) financially from this publication. J.P. declares competing financial interests in equity in GenoFAB LLC, whose value may indirectly benefit (or may be perceived to indirectly benefit) financially from this publication. D.D. declares competing financial interests as co-founder and equity holder in Lattice Automation, Inc. K.P.C. owns shares in and is an employee of Life Technologies, and his compensation is partially based upon how well the company does; he develops and sells products that incorporate or make use of SBOL; part of the paper provides an example of how that product can be used in an SBOL-based workflow. J.Y.Q., C.A.R. and D.C. work at Autodesk; J.B. works at Raytheon BBN Technologies; A.K. works at Agilent Technologies; E.S. works at Clark & Parsia; and A.V. works at DNA2.0.

You might also like



Downloadable Citations